In May 2018, CDC committed $40 million and played a pivotal role in anchoring the first close for CX Partners II.
CX will invest and create value in high quality, scalable businesses, which provide employment and on-the-job training to a significant number of unskilled and semi-skilled workers.
For funds, the countries listed here are those the fund has invested in so far.
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people. For funds, the sectors listed here are those the fund has invested in so far.
- Investment type
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Fund manager:
- CX Partners
- Start date
For direct investments, this is the date CDC committed capital to the business or project.
For funds, this is the date that CDC committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- May 2018
For direct investments, this is the total amount that CDC has committed to the business or project (it may be a combination of equity and debt).
For funds, this is the total amount that CDC has committed to the fund.
This is the investee company’s place of incorporation; or a fund’s jurisdiction.
Investments made by this fund
|Investment name||Country||Region||Sector||Start date||Status|
| Veeda Clinical Research|
Veeda offers analytical, biomarker and data management services to global pharmaceutical companies.
|India||South Asia||Health||October 2018||Active|